F. F. Fleming, W. Liu
FULL PAPER
12 H), 2.26 (dd, J = 14.0, 7.2 Hz, 1 H), 3.00–3.05 (m, 1 H), 7.20–
2.96–3.05 (m, 1 H), 7.18–7.34 (m, 5 H) ppm. 13C NMR (100 MHz,
7.34 (m, 5 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 19.3, 21.5, CDCl3): δ = 14.3, 22.6, 22.9, 27.0, 28.9, 29.0, 30.2, 31.6, 32.7, 38.2,
21.5, 24.5, 25.3, 31.4, 31.4, 37.3, 41.1, 46.5, 74.6, 122.9, 126.5,
127.1, 128.5, 146.5 ppm. MS (CI): m/z = 272 [M + H+]. HRMS
(EI): calcd. for C18H25NONa 294.1828; found 294.1811.
40.9, 122.3, 126.7, 126.9, 128.8, 144.9 ppm. MS (CI): m/z = 258
[M + H+]. HRMS (EI): calcd. for C18H27NNa+ 280.2041; found
280.2015.
(R*)-2-Methyl-2-[(R*)-2-phenylpropyl]pent-4-enenitrile (22a) and Methyl (R*)-2-Cyano-2-[(R*)-2-phenylpropyl]nonanoate (28a) and
(S*)-2-Methyl-2-[(R*)-2-phenylpropyl]pent-4-enenitrile (22b): The Methyl (S*)-2-Cyano-2-[(R*)-2-phenylpropyl]nonanoate (28b): The
general deprotonation–alkylation procedure was employed with 19
(450 mg, 2.6 mmol) and allyl bromide (327 mg, 2.7 mmol) to af-
ford, after purification by radial chromatography (EtOAc/hexanes,
1:30), 476 mg (86%) of 22 as an oily, 3.8:1 mixture of dia-
general deprotonation–alkylation procedure was employed with 26
(103 mg, 0.4 mmol) and methyl cyanoformate (41 mg, 0.48 mmol)
to afford, after purification by radial chromatography (EtOAc/hex-
anes, 1:9), 91 mg (72%) of 28 as an oily mixture of diastereomers
stereomers. For the major diastereomer 22a: IR (film): ν = 2232,
in the ratio of 3.8:1: IR (film): ν = 2241, 1744 cm–1. MS (CI): m/z
˜
˜
1642 cm–1. 1H NMR (500 MHz, CDCl3): δ = 1.07 (s, 3 H), 1.37 (d,
J = 7.3 Hz, 3 H), 1.82 (dd, J = 14.2, 7.8 Hz, 1 H), 1.95 (dd, J =
14.2, 5.2 Hz, 1 H), 2.24 (dd, J = 13.7, 7.3 Hz), 2.33 (dd, J = 13.7,
7.3 Hz, 1 H), 3.06 (sextet, J = 7.3 Hz, 1 H), 5.16 (d, J = 16.6 Hz,
= 316 [M + H+]. For the major diastereomer 28a: 1H NMR
(500 MHz, CDCl3): δ = 0.87 (t, J = 7.8 Hz, 3 H), 1.24 (d, J =
6.9 Hz, 3 H), 1.48–1.89 (m, 10 H), 2.12 (dd, J = 14.1, 6.3 Hz, 1 H),
2.24 (dd, J = 14.1, 6.3 Hz, 1 H), 3.02–3.04 (m, 1 H), 3.80 (s, 3 H),
1 H), 5.22 (d, J = 10.2 Hz, 1 H), 5.81–5.90 (m, 1 H), 7.20–7.33 (m, 7.22–7.34 (m, 5 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 14.0,
5 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 23.9, 24.1, 36.2, 37.3,
21.8, 22.5, 25.2, 28.8, 29.1, 31.6, 37.4, 38.5, 44.9, 48.8, 53.3, 118.8,
45.3, 46.6, 120.0, 123.9, 126.4, 127.0, 128.6, 131.9, 146.9 ppm. MS
126.9, 128.6, 145.8, 170.1 ppm. MS (CI): m/z = 316 [M + H+].
(CI): m/z = 281 [M + H+]. HRMS (EI): calcd. for C15H19NNa+ HRMS (EI): calcd. for C20H29NO2K+ 354.1830; found 354.1808.
236.1410; found 236.1418. For the minor diastereomer 22b: IR
For the minor diastereomer 28b: 1H NMR (500 MHz, CDCl3): δ
= 0.87 (t, J = 7.8 Hz, 3 H), 1.24 (d, J = 6.9 Hz, 3 H), 1.48–1.89
1
(film): ν = 2232 cm–1. H NMR (400 MHz, CDCl ): δ = 1.30 (s, 3
˜
3
H), 1.37 (d, J = 6.8 Hz, 3 H), 2.08–2.21 (m, 4 H), 3.02–3.11 (m, 1 (m, 10 H), 1.98–2.02 (m, 1 H), 2.36–2.41 (m, 1 H), 3.05–3.08 (m,
H), 5.06–5.19 (m, 1 H), 5.71–5.85 (m, 1 H), 7.21–7.35 (m, 5 H) 1 H), 3.16 (s, 3 H), 7.22–7.34 (m, 5 H) ppm. 13C NMR (100 MHz,
ppm. HRMS (EI): calcd. for C15H19NNa+ 236.1410; found CDCl3): δ = 23.8, 25.1, 28.8, 38.0, 39.5, 45.1, 49.3, 52.7, 119.3,
236.1398.
126.7, 127.8, 128.3, 143.8, 169.1 ppm. MS (CI): m/z = 316 [M +
H+].
(2R*,4R*)-2-Ethyl-2-methyl-4-phenylpentanenitrile
(23a)
and
(2S*,4R*)-2-Ethyl-2-methyl-4-phenylpentanenitrile (23b): The gene-
ral procedure was employed with 19 (87 mg, 0.5 mmol) and ethyl
2-Isopropyl-4-phenylpentanenitrile (27): The general procedure was
employed with 18 (239 mg, 1.5 mmol) and isopropyl iodide
iodide (94 mg, 0.6 mmol) to afford, after purification by radial (153 mg, 1.8 mmol) to afford, after purification by radial
chromatography (EtOAc/hexanes, 1:30), 56 mg (56%) of 23 as a
chromatography (EtOAc/hexanes, 1:30), 271 mg (90%) of 27 as an
4.2:1 mixture of diastereomers as an oil. For the major dia-
oily mixture of diastereomers. For the first eluting diastereomer
1
stereomer 23a IR (film): ν = 2232 cm–1. 1H NMR (400 MHz,
27a: IR (film): ν = 2235 cm–1. H NMR (500 MHz, CDCl ): δ =
˜
˜
3
CDCl3): δ = 1.03 (t, J = 7.4 Hz, 3 H), 1.06 (s, 3 H), 1.36 (d, J =
7.1 Hz, 3 H), 1.45–1.54 (m, 1 H), 1.57–1.66 (m, 1 H), 1.80 (dd, J
= 14.2, 8.0 Hz, 1 H), 1.92 (dd, J = 14.2, 5.4 Hz, 1 H), 2.99–3.07
(m, 1 H), 7.19–7.32 (m, 5 H) ppm. 13C NMR (100 MHz, CDCl3):
δ = 9.1, 23.5, 24.1, 34.0, 37.0, 37.3, 46.7, 124.1, 126.4, 127.0, 128.6,
147.1 ppm. MS (CI): m/z = 201 [M + H+]. HRMS (EI): calcd. for
1.03 (d, J = 6.5 Hz, 3 H), 1.05 (d, J = 6.5 Hz, 3 H), 1.30 (d, J =
6.8 Hz, 3 H), 1.70–1.77 (m, 1 H), 1.82–1.89 (m, 1 H), 1.90–1.98 (m,
1 H), 2.43–2.48 (m, 1 H), 2.89–2.98 (m, 1 H), 7.19–7.34 (m, 5 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 18.2, 20.9, 21.2, 29.5, 36.9,
37.4, 38.5, 120.8, 126.5, 126.8, 128.7, 145.8 ppm. HRMS (EI):
calcd. for C14H19NK+ 240.1155; found 240.1169. For the second
C14H19NNa+ 224.1415; found 224.1436. For the minor dia- eluting diastereomer 27b: IR (film): ν = 2235 cm–1. 1H NMR
˜
stereomer 23b: IR (film): ν = 2231 cm–1. 1H NMR (400 MHz, (500 MHz, CDCl3): δ = 0.96 (d, J = 6.8 Hz, 3 H), 1.00 (d, J =
˜
CDCl3): δ = 0.96 (t, J = 7.4 Hz, 3 H), 1.27 (s, 3 H), 1.35 (d, J =
6.8 Hz, 3 H), 1.32 (d, J = 6.8 Hz, 3 H), 1.67–1.70 (m, 2 H), 1.87–
7.0 Hz, 3 H), 1.55–1.63 (m, 1 H), 1.78 (dd, J = 14.2, 5.5 Hz, 1 H), 1.93 (m, 1 H), 2.04–2.18 (m, 1 H), 2.89–3.03 (m, 1 H), 7.19–7.33
2.00 (dd, J = 14.2, 7.6 Hz, 1 H), 2.96–3.03 (m, 1 H), 7.20–7.32 (m,
5 H) ppm. MS (CI): m/z = 201 [M + H+]. HRMS (EI): calcd. for
C14H19NK+ 240.1149; found 240.1153.
(m, 5 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 18.7, 20.8, 23.1,
30.4, 37.3, 38.3, 38.4, 121.1, 126.6, 126.9, 128.8, 144.9 ppm. HRMS
(EI): calcd. for C14H19NNa+ 224.1415; found 224.1463.
2-(2-Phenylpropyl)nonanenitrile (26): The general deprotonation–al-
kylation procedure was employed with 18 (191 mg, 1.2 mmol) and
iodoheptane (315 mg, 1.4 mmol) to afford, after purification by ra-
dial chromatography (EtOAc/hexanes, 1:50), 262 mg (85%) of 26
as an oily mixture of diastereomers. For the first eluting dia-
Methyl (2S*,4R*)-2-Cyano-2-isopropyl-4-phenylpentanoate (29a)
and Methyl (2R*,4R*)-2-Cyano-2-isopropyl-4-phenylpentanoate
(29b): The general deprotonation–alkylation procedure was em-
ployed with 27 (80 mg, 0.4 mmol) and methyl cyanoformate
(41 mg, 0.48 mmol) and with the modification of substituting Li-
stereomer 26a: IR (film): ν = 2235 cm–1. 1H NMR (500 MHz, NEt2 for LDA, to afford, after purification by radial chromatog-
˜
CDCl3): δ = 0.88 (t, J = 6.8 Hz, 3 H), 1.29 (d, J = 7.0 Hz, 3 H),
1.27–1.59 (m, 12 H), 1.72–1.80 (m, 1 H), 1.93–2.00 (m, 1 H), 2.45–
2.51 (m, 1 H), 2.90–2.99 (m, 1 H), 7.18–7.34 (m, 5 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 14.0, 21.3, 22.6, 27.0, 29.0, 29.0,
29.5, 31.7, 31.9, 37.3, 40.6, 122.2, 126.6, 126.8, 128.7, 145.6 ppm.
MS (CI): m/z = 258 [M + H+]. HRMS (EI): calcd. for C18H27NNa+
280.2041; found 280.2011. For the second eluting diastereomer 26b:
raphy (EtOAc/hexanes, 1:9), 51 mg (49%) of 29 as an oily 2.7:1
mixture of diastereomers: IR (film): ν = 2241, 1743 cm–1. 1H NMR
˜
(500 MHz, CDCl3): δ = 0.94 (d, J = 6.5 Hz, 3 H each), 0.99 (d, J
= 6.7 Hz, 3 H each), 1.09 (d, J = 6.8 Hz, 3 H each), 1.12 (d, J =
6.7 Hz, 3 H each), 1.22 (d, J = 7.0 Hz, 3 H each), 1.34 (d, J =
7.0 Hz, 3 H each), 2.03–2.31 (m, 3 H each), 2.93–3.07 (m, 1 H
each), 3.18 (s, 3 H each), 3.82 (s, 3 H each), 7.21–7.34 (m, 5 H
each) ppm. 13C NMR (100 MHz, CDCl3): δ = (17.9), 18.7, 21.5,
(23.7), 36.2, (36.3), 37.7, (38.1), (42.6), 42.8, (52.5), 53.0, 54.3,
IR (film): ν = 2235 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.86
˜
(t, J = 6.9 Hz, 3 H), 1.31 (d, J = 7.0 Hz, 3 H), 1.19–1.58 (m, 12
H), 1.68–1.75 (m, 1 H), 1.86–1.93 (m, 1 H), 2.10–2.17 (m, 1 H), (54.9), 117.4, (118.2), (126.6), (126.7), 127.0, (127.8), (128.2), 128.6,
706
www.eurjoc.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2009, 699–708